UNILABS NORGE AS • 981230787 • Oslo • Human health activities

This website uses cookies to enhance the user experience.

Health and social

UNILABS NORGE AS

Keywords

x-ray institutesblood banks

Links

Organization

CEO: KK
Kjetil Kollstad1973
Chairman of the board: AM
Alessandre Martin Keller1977
Years since formation: 25 years; since Nov 10, 1999
Type: Limited company
VAT registered: Yes
Number of employees: 277

Ownership

Number of shares and share classes: 1; 1 share class
Total number of shareholders: 1; person
Belongs to group of

Financials

Total operating income 2023: 607,236,924; NOK
Annual total result 2023: 29,309,675; NOK
Total equity 2023: 458,419,452; NOK

Last update: Oct 14, 2024

Management

Management / administration

Name	Role	Shares
KK Kjetil Kollstad 1973	Managing Director/CEO	-

Board

Name	Role	Shares
EB Elin Beate Olsen Granheim 1982	Board Member	-
GE Geir Ervik 1969	Board Member	-
AM Anna Margareth Skuggevik 1971	Board Member	-
SB Shalinee Basak 1985	Board Member	-
AH Anne Helene Reiten 1983	Alternate Member	-
HL Helene Lund 1986	Alternate Member	-
AM Alessandre Martin Keller 1977	Chairman	-
SK Sanna Kristina Maria Rydberg 1969	Board Member	-
AF Anders Fredrik Breitung 1972	Board Member	-

Others

Name	Role	Shares
P PRICEWATERHOUSECOOPERS AS	Auditor	-

Last update: Oct 7, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
SU Sa Unilabs	Ordinary shares	1	100 %

Shares owned by the UNILABS NORGE AS

Name	Share class	Number of shares	Share
U UNILABS LABORATORIEMEDISIN AS	Ordinary shares	358	100 %
B BYEN VÅR DRAMMEN AS	Ordinary shares	84	0.24 %

Last update: May 24, 2024

Group structure

UNILABS NORGE AS
Total operating income 2023: NOK 607,236,924
Operating profit 2023: NOK 64,360,250
Employees: 277

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	607,236,924	602,395,513	578,307,820
Annual Total Result	29,309,675	30,102,173	44,853,387
Total assets	1,206,458,774	1,187,297,007	1,193,450,988
Total liabilities	748,039,322	758,069,133	794,168,668
Total equity	458,419,452	429,227,874	399,282,320

P&L

Year	2023	2022	2021
Total operating income	607,236,924	602,395,513	578,307,820
Total operating costs	542,876,675	532,969,511	487,311,423
Operating result	64,360,250	69,426,003	90,996,397
Financial income/costs	-26,919,016	-31,031,604	-32,762,160
Profit before tax	37,441,233	38,394,398	58,234,238
Total tax & extraordinary income/cost	8,131,558	8,292,225	13,380,851
Annual Total Result	29,309,675	30,102,173	44,853,387

Balance overview

Year	2023	2022	2021
Total fixed assets	809,189,927	820,810,411	862,049,507
Total current assets	397,268,847	366,486,597	331,401,481
Total assets	1,206,458,774	1,187,297,007	1,193,450,988
Short term debt	153,662,393	175,581,026	168,355,539
Long term debt	594,376,929	582,488,107	625,813,129
Total liabilities	748,039,322	758,069,133	794,168,668
Contributed capital	381,825,441	381,825,441	381,825,441
Retained earnings	76,594,011	47,402,433	17,456,879
Total equity	458,419,452	429,227,874	399,282,320
Total equity and liabilities	1,206,458,774	1,187,297,007	1,193,450,988

Classification

Category

Health and social

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

Q

Main industrial area

Human health and social work activities

86

Activity

Human health activities

86.9

Main industrial group

Other human health activities

86.90

Industrial group

Other human health activities

86.906

Industrial group

Medical laboratories